Elisabeth Groepper

Elisabeth Groepper is an experienced professional in business development and transactions, currently serving as Manager Business Development & Transactions at CHEPLAPHARM since 2022, overseeing M&A projects in collaboration with the CEO. Prior roles include Project Manager Business Development & Strategy at Stadler, focusing on organizational development and strategic workshops, and Business Development Manager at KLEO Connect, where market analysis and client engagement were key responsibilities. Elisabeth also contributed to international business development as an Analyst at DR. KADE Health Care and as a Junior Analyst at Saxenhammer & Co. Corporate Finance GmbH, with a strong foundation in market research and investor relations. A dual Master's degree in Chinese-European Economics and Business Studies was earned at both Berlin Professional School and Southwestern University of Finance and Economics, complemented by a Bachelor’s degree in International Business from The Berlin School of Economics and Law and Anglia Ruskin University.